NASDAQ:PAHC Phibro Animal Health (PAHC) Stock Price, News & Analysis $38.80 -1.01 (-2.54%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$38.77 -0.03 (-0.08%) As of 10/23/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Phibro Animal Health Stock (NASDAQ:PAHC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Phibro Animal Health alerts:Sign Up Key Stats Today's Range$38.62▼$39.5150-Day Range$33.93▼$39.9252-Week Range$28.25▼$60.08Volume102,841 shsAverage Volume234,189 shsMarket Capitalization$1.58 billionP/E Ratio15.90Dividend Yield1.24%Price Target$47.67Consensus RatingModerate Buy Company Overview Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture. The company’s products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions. Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets. The company was founded in 1916 and is headquartered in Teaneck, New Jersey.AI Generated. May Contain Errors. Read More Phibro Animal Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks93rd Percentile Overall ScorePAHC MarketRank™: 4.658618376925 of 5 starsPhibro Animal Health scored higher than 93% of companies evaluated by MarketBeat, and ranked 24th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingModerate Buy Consensus RatingPhibro Animal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 strong buy rating, 1 buy rating, 2 hold ratings, and no sell ratings.Upside PotentialPhibro Animal Health has a consensus price target of $47.67, representing about 22.9% upside from its current price of $38.80.Amount of Analyst CoveragePhibro Animal Health has only been the subject of 2 research reports in the past 90 days.Read more about Phibro Animal Health's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth9.17% Earnings GrowthEarnings for Phibro Animal Health are expected to grow by 9.17% in the coming year, from $3.49 to $3.81 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Phibro Animal Health is 15.90, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.39.Price to Earnings Ratio vs. SectorThe P/E ratio of Phibro Animal Health is 15.90, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.33.Price to Earnings Growth RatioPhibro Animal Health has a PEG Ratio of 1.12. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPhibro Animal Health has a P/B Ratio of 4.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Phibro Animal Health's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.88% of the float of Phibro Animal Health has been sold short.Short Interest Ratio / Days to CoverPhibro Animal Health has a short interest ratio ("days to cover") of 4.06.Change versus previous monthShort interest in Phibro Animal Health has recently decreased by 10.62%, indicating that investor sentiment is improving significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldPhibro Animal Health pays a meaningful dividend of 1.24%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthPhibro Animal Health does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Phibro Animal Health is 19.67%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Phibro Animal Health will have a dividend payout ratio of 12.60% next year. This indicates that Phibro Animal Health will be able to sustain or increase its dividend.Read more about Phibro Animal Health's dividend. News and Social Media3.0 / 5News Sentiment0.84 News SentimentPhibro Animal Health has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Phibro Animal Health this week, compared to 5 articles on an average week.Search InterestOnly 2 people have searched for PAHC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Phibro Animal Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Phibro Animal Health insiders have not sold or bought any company stock.Percentage Held by Insiders48.47% of the stock of Phibro Animal Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions99.34% of the stock of Phibro Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Phibro Animal Health's insider trading history. Receive PAHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PAHC Stock News HeadlinesPhibro Animal Health (PAHC) Stock May Still Offer Value At This PriceOctober 24 at 4:03 AM | finance.yahoo.comWill Phibro (PAHC) beat estimates again in its next earnings report?October 23 at 6:01 PM | msn.comBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now. Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen. Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch.October 25 at 1:00 AM | Decentralized Masters (Ad)What Is Drawing Attention To Phibro Animal Health (PAHC) Today?October 9, 2026 | finance.yahoo.comIs it the Right Time to Add Phibro Stock to Your Portfolio?October 8, 2026 | finance.yahoo.comWhy Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?September 25, 2026 | finance.yahoo.comPhibro Animal Health (PAHC): Buy, sell, or hold post Q2 earnings?September 24, 2026 | msn.comBranded pharmaceuticals stocks Q2 in review: Phibro Animal Health (NASDAQ:PAHC) vs peersSeptember 23, 2026 | msn.comSee More Headlines PAHC Stock Analysis - Frequently Asked Questions How have PAHC shares performed this year? Phibro Animal Health's stock was trading at $37.36 at the beginning of the year. Since then, PAHC stock has increased by 3.9% and is now trading at $38.80. How were Phibro Animal Health's earnings last quarter? Phibro Animal Health Corporation (NASDAQ:PAHC) announced its quarterly earnings results on Wednesday, August, 26th. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.14. The business had revenue of $396.75 million for the quarter, compared to the consensus estimate of $381.18 million. Phibro Animal Health had a net margin of 6.57% and a trailing twelve-month return on equity of 37.86%. Read the conference call transcript. When did Phibro Animal Health IPO? Phibro Animal Health (PAHC) raised $217 million in an IPO on Friday, April 11th 2014. The company issued 12,745,392 shares at $16.00-$18.00 per share. Who are Phibro Animal Health's major shareholders? Phibro Animal Health's top institutional shareholders include Cardinal Capital Management (0.26%), Kings Path Partners LLC (0.04%), James Investment Research Inc. (0.02%) and Inspire Investing LLC (0.01%). Insiders that own company stock include Jack Bendheim and E Thomas Corcoran. View institutional ownership trends. How do I buy shares of Phibro Animal Health? Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Phibro Animal Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Phibro Animal Health investors own include Merck & Co., Inc. (MRK), NVIDIA (NVDA), PayPal (PYPL), Eli Lilly and Company (LLY), Phillips 66 (PSX), Energy Transfer (ET) and Applied Materials (AMAT). Company Calendar Last Earnings8/26/2026Record date for 9/23 Dividend9/02/2026Ex-Dividend for 9/23 Dividend9/02/2026Dividend Payable9/23/2026Today10/25/2026Next Earnings (Estimated)11/04/2026Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 PAHC's financial health is in the Green zone, according to TradeSmith. PAHC has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:PAHC CIK1069899 Webwww.pahc.com Phone(201) 329-7300Fax201-329-7399Employees2,605Year Founded1946Price Target and Rating Average Price Target for Phibro Animal Health$47.67 High Price Target$50.00 Low Price Target$44.00 Potential Upside/Downside+22.9%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)$2.44 Trailing P/E Ratio15.90 Forward P/E Ratio11.12 P/E Growth1.12Net Income$99.72 million Net Margins6.57% Pretax Margin9.05% Return on Equity37.86% Return on Assets9.18% Debt Debt-to-Equity Ratio1.84 Current Ratio2.96 Quick Ratio1.27 Sales & Book Value Annual Sales$1.52 billion Price / Sales1.04 Cash Flow$4.58 per share Price / Cash Flow8.48 Book Value$9.50 per share Price / Book4.08Miscellaneous Outstanding Shares40,600,000Free Float20,922,000Market Cap$1.58 billion OptionableOptionable Beta0.42 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:PAHC) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersWhy tech stocks are deadAI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the b...Porter & Company | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | SponsoredThe $100 Stock Behind Elon's Next MoveA small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for mor...Paradigm Press | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phibro Animal Health Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Phibro Animal Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
